A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-negative Pneumonia. Pharmacokinetics and Dialytic Clearance of Isavuconazole During in vitro and in vivo Continuous Renal Replacement Therapy. DOI: 10.1128/AAC.01426-19.īiagi M, Butler D, Tan X, Qasmieh S, Tejani K, Patel S, Rivosecchi RM, Nguyen MH, Shields RK, Wenzler E. Searching for the Optimal Treatment for Metallo- and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam. Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still Be Hard to Treat. DOI: 10.1017/ice.2020.334īutler DA, Biagi M, Tan X, Qasmieh S, Bulman ZP, Wenzler E. ![]() Infection Control and Hospital Epidemiology. ![]() Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data. DOI: 10.1093/jac/dkaa480īutler DA, Biagi M, Gupta V, et al. Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (Ame) gene aac(6’)-Ib. Pharmacokinetics, pharmacodynamics, and dose optimization of cefiderocol during continuous renal replacement therapy. ![]() Wenzler E, Butler D, Tan X, Katsube T, Wajima T.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |